Network pharmacological analyses have suggested that the mechanism of action of flavonoids against liver fibrosis may be related to inhibition of the NF-κB pathway by inhibition of IKKβ expression (An et al., 2021). The gene discussed is NFKB1; the disease is Hepatic fibrosis.